Use of 1-(aminoalkyl)-3-(benzyl)-quinoxaline-2-one derivatives f

Details Use of 1-(aminoalkyl)-3-(benzyl)-quinoxaline-2-one derivatives f Use of 1-(aminoalkyl)-3-(benzyl)-quinoxaline-2-one derivatives f

1992-11-16

1996-10-08

Jordan, Kimberly

Drug, bio-affecting and body treating compositions

Designated organic active ingredient containing

Heterocyclic carbon compounds containing a hetero ring...

514212, A61K 3155, A61K 31495, A61K 3150

Patent

active

055631401

ABSTRACT:
Compounds of the formula ##STR1## wherein R.sub.1 and R.sub.2 are each independently hydrogen, methyl, ethyl, propyl, butyl or R.sub.1 and R.sub.2 are together cycloalkyl;

REFERENCES:
patent: 5037848 (1991-08-01), Olney
"Studies of experimental cerebral artery dilatation (with caroverin fumarate", Neurological Surgery, Abstracts of the 7th International Congress of Neurological Surgery, Munich, Germany (Jul. 12-18, 1981), Supplement to Neurochirugia, Abstract No. 8.3.1, vol. 0, No. SU, p. 332, J. O. Widauer.
B. Meldrum, "Excitatory amino acid neurotoxicity and neurodegenerative disease", Trends in Pharmacological Sciences, vol. 11, No. 9 (Sep. 1990), pp. 379-387.
M. Ishida et al, "Reduction of glutamate responses at the crayfish neuromuscular junction", Brain Research, vol. 266, No. 1 (Apr. 25, 1983), pp. 174-177.
Y. Kudo et al, "Effects of caroverine and diltiazem on synaptic responses, L-glutamate-induced depolarization and potassium efflux in the frog spinal cord", British Journal of Pharmacology, vol. 83, No. 3 (Nov. 1984), pp. 813-820.
H. Shinozaki, "Pharmacology of the Glutamate Receptor", Progress in Technology, vol. 30 (1988), pp. 399-435.
Kessler et al, "Quinoxaline derivatives are high-affinity antagonists of the NMDA receptor-associated glycine sites", Brain Research, vol. 489 (1989), pp. 377-382.
A. Mule et al, "Terz-amminoalchilderivati di chinossalinoni ad attivita analgesica", Il Farmaco Edizione Scientifica, vol. 43, No. 7-8 (Aug. 1988), pp. 613-618.
Subsidia Medica, 22, 3, pp. 78-85 (1970).
Koppi et al, "Calcium-Channel-Blocking Agent in the Treatment of Acute Alcohol Withdrawal--Caroverine versus Meprobamate in a Randomized Double-Blind Study", Neuropsychobiology, 17, pp. 49-52 (1987).
Presslich et al, "Oesterreichische Apothekerzeitung", 38/39, p. 757 (1984).
Honore et al, "Quinoxalinediones: Potent Competitive Non-NMDA Glutamate Receptor Antagonists", Science, 241, pp. 701-703 (1988).
Merck Index, 11th Ed., 1989, #1864.
CA 99:3359, Ishida et al., 1983.
Kaplan Clinical Hypertension p. 235 1986.
Merck Manual p. 1308-1309; 1324-1327 1982.

Affiliated with

Also associated with

Rating

Use of 1-(aminoalkyl)-3-(benzyl)-quinoxaline-2-one derivatives f does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Use of 1-(aminoalkyl)-3-(benzyl)-quinoxaline-2-one derivatives f, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Use of 1-(aminoalkyl)-3-(benzyl)-quinoxaline-2-one derivatives f will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-57415